BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rutgers Addiction Research Center (RARC) - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rutgers Addiction Research Center (RARC)
X-ORIGINAL-URL:https://addiction.rutgers.edu
X-WR-CALDESC:Events for Rutgers Addiction Research Center (RARC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260908T120000
DTEND;TZID=America/New_York:20260908T130000
DTSTAMP:20260704T121834
CREATED:20260527T183732Z
LAST-MODIFIED:20260527T183732Z
UID:11281-1788868800-1788872400@addiction.rutgers.edu
SUMMARY:Yale Addiction Medicine 10th Annual Schottenfeld Lecture: Yngvild Olsen\, MD\, MPH
DESCRIPTION:The Yale Program in Addiction Medicine is pleased to welcome Yngvild Olsen\, MD\, MPH\, as speaker for the 10th Annual Schottenfeld Lecture on September 8th\, 2026. \nThis event will be held in a virtual format & Brady Memorial LaboratoryAuditorium (B131)310 Cedar StreetNew Haven\, CT \nRegistration: click here. \nDr. Yngvild Olsen is a National Advisor with Manatt Health. A nationally recognized leader in addiction medicine\, public health policy and clinical care integration\, Yngvild provides strategic counsel to clients working with substance use disorders (SUDs)\, particularly opioid use disorder\, primary care integration and Medicaid\, as well as state block grants\, Medicaid waivers and behavioral health integration efforts. \nWith over two decades of experience across clinical\, academic and governmental roles at the local\, state and federal level—including leadership at REACH Health Services\, Johns Hopkins and the Baltimore Substance Abuse System—Yngvild brings unmatched knowledge\, deep policy insight and a strong national network. She is board-certified in addiction medicine\, trained in general internal medicine and is widely respected for her contributions to advancing addiction treatment and recovery nationwide. She has also advised states on the use of Medicaid waivers\, block grant alignment and behavioral health integration strategies. \nMost recently\, Yngvild served as the Director of the Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration (SAMHSA)\, where she oversaw $5 billion in grant funding and led national efforts to expand access to care\, strengthen the behavioral health workforce and promote evidence-based practices in the treatment of SUDs. Yngvild has also held leadership roles at the American Society of Addiction Medicine (ASAM)\, where she led the association’s policy position development on a range of substance use-related issues and provided input on the ASAM Criteria or continuum of care\, which is the most widely used and comprehensive set of standards and framework for the specialized treatment of patients with addiction and co-occurring conditions.
URL:https://addiction.rutgers.edu/event/yale-addiction-medicine-10th-annual-schottenfeld-lecture-yngvild-olsen-md-mph/
END:VEVENT
END:VCALENDAR